#USA #New York #Kidney Care #National Kidney Foundation #Dr. Marc Hurlbert

Leadership Change at NKF

On May 20, 2026, the National Kidney Foundation (NKF) officially announced the appointment of Dr. Marc Hurlbert as the new Chief Executive Officer, starting July 1, 2026. Dr. Hurlbert, a seasoned pharmacologist and healthcare leader, has dedicated over 25 years to enhancing research, patient advocacy, and health equity within major healthcare organizations. His dedication to improving healthcare access and patient support dovetails with NKF's mission, setting the stage for a promising future for the organization.

Background of Dr. Hurlbert

Dr. Hurlbert's impressive career includes overseeing more than $750 million in funding for hospitals, universities, and community organizations as part of his advocacy for public health initiatives. His extensive experience in building collaborations across various sectors—ranging from government and academia to the biotechnology and pharmaceutical industries—positions him uniquely at the helm of NKF. Kevin Longino, the outgoing CEO of NKF, emphasized that Dr. Hurlbert's commitment to public health and his ability to support patients and families in dire circumstances make him an ideal leader for the foundation.

Dr. Hurlbert personally connects to kidney disease as he has been a caregiver for his brother, who was diagnosed with chronic kidney disease in 2016. His empathy helps inform his mission-driven approach, ensuring a compassionate framework within NKF.

Vision for the Future

As NKF continues its legacy spanning over 75 years, Dr. Hurlbert aims to further the foundation's objectives through innovative approaches and modern technologies. He stated, "I am honored to join NKF as its next CEO, building off a rich 75-year history of supporting patients and families facing a diagnosis of kidney disease." This vision includes leveraging cutting-edge tools such as technology and artificial intelligence, honed research investments aimed at better supporting kidney care. Dr. Hurlbert advocates for expanding educational programs to empower healthcare professionals and community members alike, further enhancing the resources available for those affected by kidney disease.

The NKF has been instrumental in improving kidney health through initiatives like its KDOQI guidelines and advancing equitable access to healthcare, demonstrated by innovations like race-free eGFR equations. Under Dr. Hurlbert's leadership, NKF seeks to amplify these initiatives, further enhancing early detection, transplantation, and prevention efforts for kidney disease.

Leadership Transition

As the leadership transition begins, Kevin Longino will work closely with Dr. Hurlbert to ensure continuity and support across all initiatives. The decision to appoint Dr. Hurlbert followed a thorough national search, in line with NKF's long-term vision for its leadership and its strategic advancement in the realm of kidney health.

According to Anne Barr, Chair of the National Board, Dr. Hurlbert encapsulates the balance of being both a visionary and practical leader. He has a firm scientific background, fundraising expertise, and a profound sense of compassion—qualities that will undoubtedly guide NKF into its next chapter of growth and patient advocacy.

In conclusion, Dr. Marc Hurlbert emerges as a beacon of hope for the National Kidney Foundation, driven by a mission-oriented focus and a commitment to revolutionizing kidney care. His leadership promises to build on NKF's previous achievements while tackling the ever-evolving challenges faced by kidney disease patients across the nation. Through advocacy, education, and innovative care, NKF plans to continue shaping the future and saving lives impacted by kidney disease, ensuring that no one faces these challenges alone.

For more information on NKF and its programs, visit kidney.org.